Oegstgeest, the Netherlands, February 17, 2022 – ISA Pharmaceuticals will be attending the following in person scientific and business conferences from February through to April 2022 (subject to travel restrictions), in addition to virtual conferences.

BioCapital Europe

Date: 10 March 2022, Amsterdam

American Association for Cancer Research (AACR) annual meeting

Date: 8-13 April 2022, New Orleans

 2nd Chronic HBV drug development

Date: 25-27 April 2022, Boston

If you would like to meet with the ISA Pharmaceutical team at any of the above events, please contact us!